406 related articles for article (PubMed ID: 28584137)
1. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins.
Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137
[TBL] [Abstract][Full Text] [Related]
2. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
Vila-Farrés X; Callarisa AE; Gu X; Savage PB; Giralt E; Vila J
Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218
[TBL] [Abstract][Full Text] [Related]
3. Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.
Lee JY; Choi MJ; Choi HJ; Ko KS
Antimicrob Agents Chemother; 2016 Jan; 60(1):609-12. PubMed ID: 26459897
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility to various antibiotics of colistin-resistant gram-negative bacterial isolates in a general tertiary hospital in Crete, Greece.
Samonis G; Matthaiou DK; Kofteridis D; Maraki S; Falagas ME
Clin Infect Dis; 2010 Jun; 50(12):1689-91. PubMed ID: 20482269
[No Abstract] [Full Text] [Related]
5. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
Vidaillac C; Benichou L; Duval RE
Antimicrob Agents Chemother; 2012 Sep; 56(9):4856-61. PubMed ID: 22751540
[TBL] [Abstract][Full Text] [Related]
6. Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates.
Choi MJ; Ko KS
J Antimicrob Chemother; 2014 Jan; 69(1):275-7. PubMed ID: 23997018
[No Abstract] [Full Text] [Related]
7. Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates.
Choi MJ; Park YK; Peck KR; Ko KS
Int J Antimicrob Agents; 2014 Nov; 44(5):475-6. PubMed ID: 25443890
[No Abstract] [Full Text] [Related]
8. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
[TBL] [Abstract][Full Text] [Related]
9. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study.
Matthaiou DK; Michalopoulos A; Rafailidis PI; Karageorgopoulos DE; Papaioannou V; Ntani G; Samonis G; Falagas ME
Crit Care Med; 2008 Mar; 36(3):807-11. PubMed ID: 18431267
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
[TBL] [Abstract][Full Text] [Related]
11. Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria.
Sun W; Weingarten RA; Xu M; Southall N; Dai S; Shinn P; Sanderson PE; Williamson PR; Frank KM; Zheng W
Emerg Microbes Infect; 2016 Nov; 5(11):e116. PubMed ID: 27826141
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the in vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care centre in Western Turkey.
Ece G; Samlioglu P; Atalay S; Kose S
Infez Med; 2014 Mar; 22(1):36-40. PubMed ID: 24651089
[TBL] [Abstract][Full Text] [Related]
15. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
[TBL] [Abstract][Full Text] [Related]
16. Performances of the Rapid Polymyxin
Lescat M; Poirel L; Jayol A; Nordmann P
Microb Drug Resist; 2019 May; 25(4):520-523. PubMed ID: 30508392
[No Abstract] [Full Text] [Related]
17. The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli.
Ayerbe-Algaba R; Gil-Marqués ML; Miró-Canturri A; Parra-Millán R; Pachón-Ibáñez ME; Jiménez-Mejías ME; Pachón J; Smani Y
Int J Antimicrob Agents; 2019 Oct; 54(4):507-512. PubMed ID: 31299296
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of the potential for resistance development to ceragenin CSA-13.
Pollard JE; Snarr J; Chaudhary V; Jennings JD; Shaw H; Christiansen B; Wright J; Jia W; Bishop RE; Savage PB
J Antimicrob Chemother; 2012 Nov; 67(11):2665-72. PubMed ID: 22899801
[TBL] [Abstract][Full Text] [Related]
19. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
Doymaz MZ; Karaaslan E
Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
[No Abstract] [Full Text] [Related]
20. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
